• Global Livestock mRNA Vaccines market size was valued at USD 13.8 million in 2024. The market is projected to grow from USD 15.3 million in 2025 to USD 28.4 million by 2032, exhibiting a CAGR of 11.0% during the forecast period.
Email:
Report Studies
• Livestock mRNA vaccines represent a groundbreaking advancement in veterinary medicine, utilizing messenger RNA technology to immunize farm animals against infectious diseases. These vaccines function by introducing genetic instructions that prompt animal cells to produce pathogen-specific proteins, thereby stimulating an immune response without exposing livestock to actual viruses or bacteria. This innovative approach enables rapid vaccine development cycles a critical advantage in combatingemergingzoonoticthreats.
Email: help@intelmarketresearch.com +91 9169164321
By Types
(Pigs)
By Applications
• Infectious Disease Prevention
Production Enhancement
Zoonotic Disease Control
Key Players :
•Ceva Animal Health (France)
•Merck Animal Health (U.S.)
•Areterna (Germany)
•Bayer (Germany)
•BioNTech (Germany)
•Genvax Technologies (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
